Related Experiment Videos
Adult-onset atopic dermatitis in a patch test population.
Vito Ingordo1, Giuliano D'Andria, Corrado D'Andria
1Department of Dermatology, Italian Navy Main Hospital M.O. Giulio Venticinque, Taranto, Italy. vitoingo@tin.it
Summary
Adult-onset atopic dermatitis (AD) is often overlooked, but this study found it in 8.8% of eczemas. Early diagnosis is key, as adult-onset AD can present differently from childhood AD.
Area of Science:
- Dermatology
- Allergology
- Epidemiology
Background:
- Epidemiological studies on atopic dermatitis (AD) predominantly focus on childhood onset, with limited data on adult-onset AD.
- Adult-onset AD is observed in clinical practice, necessitating further investigation into its prevalence and characteristics.
Purpose of the Study:
- To determine the prevalence of adult-onset AD within a patch-test population.
- To compare the clinical features and diagnostic outcomes between early-onset AD (EOG) and adult-onset AD (AOG) groups.
Main Methods:
- A retrospective analysis of 502 adults with eczematous dermatitis undergoing patch testing, prick testing, and serum IgE measurement.
- Patients were categorized into EOG (onset ≤17 years) and AOG (onset ≥18 years) based on age of disease onset.
- Diagnostic criteria included standard and specialized patch tests, atopy patch tests (APT), and clinical evaluation.
Main Results:
- Adult-onset AD accounted for 8.8% of all eczemas, with 5.6% being 'sole' AD and 3.2% associated with contact sensitization.
- Mean SCORAD index decreased with increasing age of onset.
- No significant differences were found between EOG and AOG regarding sensitization prevalence, 'pure' vs. 'mixed' AD, or APT outcomes. Hands were the most frequently affected site in AOG.
Conclusions:
- A notable proportion of patch-test-negative eczematous cases may represent adult-onset AD.
- Further allergological testing (prick tests, IgE levels) and clinical assessment are recommended for suspected adult-onset AD.
- Larger studies are needed to validate these findings and refine diagnostic approaches for adult-onset AD.